Search Results 41-50 of 15651 for lewy body dementia
Also, to test the hypothesis that prospective intervention with a DPP4 inhibitor or SGLT2 inhibitor improves Parkinson's disease and Lewy Body Dementia related ...
Open-label Study of Nelotanserin in Lewy Body Dementia With Visual Hallucinations or REM Sleep Behavior Disorder · Overview · Participation eligibility.
Dementia with Lewy bodies (DLB) is part of Lewy body dementia, the 2nd-most-common degenerative dementia in the U.S. It is also one of the Alzheimer's ...
May your appreciation of the positive elements in your life, past and present, help you to cope with and even benefit from your experience of Dementia Lewy Body ...
... dementias. They might be prescribed for people with vascular dementia, Parkinson's disease dementia and Lewy body dementia. Side effects can include nausea ...
A Study of Change in Imaging Biomarkers of Dementia with Lewy Bodies (DLB) and Associations with Cognitive and Functional Decline · Overview · Participation ...
Clinical Trials · Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies · More about research at Mayo Clinic · Mayo Clinic ...
The Lewy Body Dementia Center Without Walls seeks to learn more about how genetics and interactions between amyloid and α-synuclein affect symptom presentation, ...
The purpose of this study is to examine the effects of the medication Armodafinil in patients who have dementia with Lewy bodies which is associated with ...
... Lewy body dementia, frontotemporal dementia and other dementia conditions. Ultimately, center researchers aim to prevent, delay and possibly cure ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.